Insider Transactions in Q3 2025 at Travere Therapeutics, Inc. (TVTX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2025
|
Peter Heerma CHIEF COMMERCIAL OFFICER |
SELL
Bona fide gift
|
Direct |
891
-0.69%
|
-
|
|
Sep 22
2025
|
Elizabeth E Reed Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
10,000
-10.01%
|
$250,000
$25.0 P/Share
|
|
Sep 22
2025
|
Elizabeth E Reed Chief Legal Officer and GC |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+9.1%
|
$190,000
$19.08 P/Share
|
|
Sep 04
2025
|
Christopher R. Cline CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
119
-0.13%
|
$2,261
$19.71 P/Share
|
|
Sep 03
2025
|
Christopher R. Cline CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
454
-0.49%
|
$8,172
$18.2 P/Share
|
|
Aug 27
2025
|
Christopher R. Cline CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
470
-0.5%
|
$7,990
$17.31 P/Share
|
|
Jul 01
2025
|
Jula Inrig CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
815
-0.91%
|
$11,410
$14.65 P/Share
|